Stocks · News reference
Nephros shares are trading higher after the company reported better-than-expected Q2 financial results.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 6, 2026, 9:16 PM
- Checked
- Aug 6, 2026, 9:17 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
12 Industrials Stocks Moving In Thursday's After-Market Session
Gainers Innovate (NYSE:VATE) shares moved upwards by 36.9% to $10.15 during Thursday's after-market session. The market value of their outstanding shares is at $103.1 million. As per the news, the Q2 earnings
Read original at benzingaNephros Q2 EPS $0.11 Beats $0.00 Estimate, Sales $6.017M Beat $4.994M Estimate
Nephros (NASDAQ:NEPH) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.00 by Infinity percent. This is a 450 percent increase over earnings of $0.02 per share from the same
Read original at benzingaNephros to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET
Nephros, Inc. (Nasdaq: NEPH), a water technology and filtration solutions company, announced that its President and CEO Robert Banks will present at Maxim Group LLC's virtual 'Health, Wellness & Longevity' conference on July 22, 2026, at 10:00 a.m. ET. The conference brings together leaders from companies innovating in beverages, food, supplements, and longevity sectors to discuss consumer preferences and emerging trends.
Read original at globenewswire-inc